{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:12:06Z","timestamp":1793664726637,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jceh.2023.101322","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T03:04:34Z","timestamp":1702695874000},"page":"101322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Features, Laboratory Characteristics and Outcome from Oral Contraceptives-induced Liver Injury in 43 Consecutive Patients and a Brief Review of Published Reports"],"prefix":"10.1016","volume":"14","author":[{"given":"Mallikarjun","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Devarbhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-6478","authenticated-orcid":false,"given":"Y.M.","family":"Pavan Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal K.","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.101322_bib1","first-page":"728","article-title":"The NAMS 2017 hormone therapy position statement advisory panel. The 2017 hormone therapy position statement of the North American Menopause Society","volume":"24","author":"Pinkerton","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.jceh.2023.101322_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/bcr475","article-title":"Hormone replacement therapy (HRT): indications and side effects","volume":"4","author":"Whitehead","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jceh.2023.101322_bib3","first-page":"449","article-title":"How best to manage dysfunctional uterine bleeding: irregular or unusually heavy periods are a common complaint. Most often, the condition is benign and can by managed conservatively","volume":"59","author":"Maness","year":"2010","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.jceh.2023.101322_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.grf.0000159540.11974.17","article-title":"Hormonal management of abnormal uterine bleeding","volume":"48","author":"Singh","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jceh.2023.101322_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.jceh.2023.101322_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2796.1993.tb00745.x","article-title":"Liver damage from low-dose oral contraceptives","volume":"234","author":"Lindgren","year":"1993","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jceh.2023.101322_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-196707000-00001","article-title":"Recurrent intrahepatic cholestasis of pregnancy: report of six cases, and review of the literature","volume":"46","author":"Up","year":"1967","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2023.101322_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.contraception.2009.11.007","article-title":"Clinical pharmacokinetics and interaction of centchroman\u2014a mini review","volume":"81","author":"Lal","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jceh.2023.101322_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.1011","article-title":"Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders","volume":"21","author":"Singh","year":"2001","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jceh.2023.101322_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030373","article-title":"Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill","volume":"9","author":"Kabra","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jceh.2023.101322_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/medicina58111503","article-title":"Evaluation of the safety and efficacy of ormeloxifene, a selective estrogen receptor modulator and medroxyprogesterone acetate in women with non-structural abnormal uterine bleeding: a randomized clinical trial","volume":"58","author":"Mir","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.jceh.2023.101322_bib12","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101322_bib13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.101322_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jceh.2020.04.012","article-title":"Indian national association for the study of the liver consensus statement on acute liver failure (Part 1): epidemiology, pathogenesis, presentation and prognosis","volume":"10","author":"Anand","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.101322_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2023.101322_bib16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jceh.2023.101322_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/bmj.2.5419.1264-d","article-title":"Oral contraception and liver damage","volume":"2","author":"Sotaniemi","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.jceh.2023.101322_bib18","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1345\/aph.1P201","article-title":"Cytolytic hepatitis possibly related to levonorgestrel\/ethinylestradiol oral contraceptive use: 2 case reports","volume":"44","author":"Elouni","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jceh.2023.101322_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101322_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.101322_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1665-2681(19)30886-5","article-title":"Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports","volume":"13","author":"Hern\u00e1ndez","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2023.101322_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.101322_bib23","doi-asserted-by":"crossref","first-page":"16625","DOI":"10.1074\/jbc.M602723200","article-title":"Estrogen receptor \u03b1 mediates 17\u03b1-ethynylestradiol causing hepatotoxicity","volume":"281","author":"Yamamoto","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2023.101322_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0002-9378(74)90029-5","article-title":"Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives","volume":"119","author":"Drill","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jceh.2023.101322_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.12968\/hmed.2019.80.8.476","article-title":"A\u00a0rare case of norethisterone-related drug-induced liver injury","volume":"80","author":"Pool","year":"2019","journal-title":"Br J Hosp Med (Lond)."},{"key":"10.1016\/j.jceh.2023.101322_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1159\/000481159","article-title":"Levonorgestrel-releasing intrauterine device-related acute liver injury","volume":"11","author":"Cheema","year":"2018","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jceh.2023.101322_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jceh.2017.01.001","article-title":"Norethisterone related drug induced liver injury: a series of 3 cases","volume":"7","author":"Choudhary","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.101322_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gastrohep.2008.06.001","article-title":"Toxic hepatitis associated with the use of medroxyprogesterone","volume":"32","author":"Hidalgo","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.101322_bib29","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2023.101322_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/lt.21127","article-title":"Green tea extracts and acute liver failure: the need for caution in their use and diagnostic assessment","volume":"13","author":"Jimenez-Saenz","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2023.101322_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/qjmed\/hci031","article-title":"Norethisterone-induced cholestasis","volume":"98","author":"Anand","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2023.101322_bib32","first-page":"49","article-title":"Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia","volume":"15","author":"Altinta\u015f","year":"2004","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.101322_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0142(19890201)63:3<438::AID-CNCR2820630307>3.0.CO;2-O","article-title":"Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer","volume":"63","author":"Foitl","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2023.101322_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(75)91617-7","article-title":"Jaundice associated with norethisterone-acetate treatment of breast cancer","volume":"305","author":"Langlands","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2023.101322_bib35","first-page":"186","article-title":"Jaundice with blockage after therapy with norethisterone acetate","volume":"7","author":"Werner","year":"1969","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2023.101322_bib36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM196211292672208","article-title":"Jaundice associated with norethindrone acetate therapy","volume":"267","author":"Perez-Mera","year":"1962","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2023.101322_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0010-7824(97)00174-1","article-title":"In\u00a0vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women","volume":"56","author":"Kuhnz","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jceh.2023.101322_bib38","article-title":"Norethisterone-induced liver injury and a short survey among gynecologists","volume":"15","author":"Rather","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2023.101322_bib39","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.dld.2015.02.010","article-title":"Oral contraceptive-induced hepatic sinusoidal dilatation","volume":"47","author":"Kumar","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2023.101322_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-20-1064","article-title":"Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?","volume":"184","author":"Stangl","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jceh.2023.101322_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236506","article-title":"Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer","volume":"15","author":"Yoo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.101322_bib42","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(05)60331-5","article-title":"Raloxifene-associated hepatitis","volume":"352","author":"Vilches","year":"1998","journal-title":"Lancet"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323008551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323008551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:12:56Z","timestamp":1715721176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323008551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0973688323008551"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.101322","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Features, Laboratory Characteristics and Outcome from Oral Contraceptives-induced Liver Injury in 43 Consecutive Patients and a Brief Review of Published Reports","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.101322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101322"}}